<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Maximilian Lombardo · Writing</title><description>Essays on AI, drug discovery, and the business of biology.</description><link>https://www.maximilianlombardo.com/</link><item><title>Regulation Is Not Friction. It Is a Feature.</title><link>https://www.maximilianlombardo.com/writing/regulation-is-not-friction-it-is/</link><guid isPermaLink="true">https://www.maximilianlombardo.com/writing/regulation-is-not-friction-it-is/</guid><description>While consumer AI faces volatility, rapid FDA policy maturation is converting pharma AI uncertainty into investable risk.</description><pubDate>Tue, 17 Feb 2026 00:00:00 GMT</pubDate></item><item><title>How Eli Lilly Became a Trillion-Dollar AI Powerhouse</title><link>https://www.maximilianlombardo.com/writing/how-eli-lilly-became-a-trillion-dollar/</link><guid isPermaLink="true">https://www.maximilianlombardo.com/writing/how-eli-lilly-became-a-trillion-dollar/</guid><description>The Full-Stack Playbook Every Pharma Will Copy</description><pubDate>Tue, 27 Jan 2026 00:00:00 GMT</pubDate></item><item><title>JPM 2026: What the AI Partnership Wave Signals for Drug Discovery</title><link>https://www.maximilianlombardo.com/writing/jpm-2026-what-the-ai-partnership/</link><guid isPermaLink="true">https://www.maximilianlombardo.com/writing/jpm-2026-what-the-ai-partnership/</guid><description>Clinical validation arrived. Now comes the pay-to-play.</description><pubDate>Tue, 13 Jan 2026 00:00:00 GMT</pubDate></item></channel></rss>